According to a new report from Intel Market Research, the Europe Graft Versus Host Disease (GvHD) market was valued at USD 345.6 million in 2024 and is projected to reach USD 567.8 million by 2030, growing at a CAGR of 8.6% during the forecast period (2025–2030). This growth is driven by increasing stem cell transplantation rates, advancements in immunosuppressive therapies, and improved...

"Executive Summary G-Protein Coupled Receptors (GPCRs) Market Size and Share Across Top Segments CAGR Value By utilizing few steps or a number of steps, the process of formulating this G-Protein Coupled Receptors (GPCRs) Market research report is commenced with the expert advice. The base year for calculation in the report is considered, while the historic year suggests how the G-Protein...

Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

The long-term viability of the India Cancer Immunotherapy Market hinges on the industry's ability to scale effectively while maintaining strict quality standards. Sustainability in this context means creating a resilient supply chain that can withstand global disruptions, coupled with a focus on environmentally conscious manufacturing processes. As the industry moves into a new phase of growth,...

"Executive Summary Next-Generation Targeted Oncology Drug Market Size and Share Analysis Report CAGR Value The global Next-Generation Targeted Oncology Drug Market research report has incorporated the analysis of different factors that augment the market's growth. It has various sections that provide the scope of different segments and applications that can potentially influence the market...

The North America Netherton Syndrome Market is positioned to maintain a leading role in the global rare-disease therapeutics landscape through 2031, supported by increasing disease awareness, advanced diagnostic capabilities, research funding, and the development of innovative treatment candidates. Netherton syndrome (NS) is a rare multisystem genetic disorder characterized by congenital...

The North America Rare Neurological Disease Treatment Market is positioned as a leading regional market, supported by strong pharmaceutical and biotechnology capabilities, advanced healthcare infrastructure, and substantial investment in research and development. The region’s dominance is attributed particularly to the presence of major manufacturers and an expanding pipeline of...

"Relapsed or Refractory Diffuse Large B-cell Lymphoma Market Summary: According to the latest report published by Data Bridge Market Research, the Relapsed or Refractory Diffuse Large B-cell Lymphoma Market  CAGR Value The global Relapsed or Refractory Diffuse Large B-cell Lymphoma market size was valued at USD 1.89 billion in 2025 and is expected to reach USD...

Global Demand Outlook for Executive Summary Steroid Injections Market Size and Share CAGR Value Data Bridge Market Research analyses that the global steroid injections market, valued at USD 4.87 Billion in 2022, is expected to reach USD 8.17 Billion by 2030, growing at a CAGR of 6.70% during the forecast period of 2023 to 2030 Steroid Injections Market research reports consist of a...

"Executive Summary Neuroendocrine Tumors Market Size and Share: Global Industry Snapshot CAGR Value The global neuroendocrine tumors market size was valued at USD 3.56 billion in 2024 and is expected to reach USD 7.87 billion by 2032, at a CAGR of 10.4% during the forecast period The research and analysis carried out in this Neuroendocrine Tumors report...

Detailed Analysis of Executive Summary Essential Thrombocytosis Treatment Market Size and Share CAGR Value The global essential thrombocytosis treatment market size was valued at USD 968.50 Million in 2025 and is expected to reach USD 1509.03 Million by 2033, at a CAGR of 5.70% during the forecast period The Essential Thrombocytosis Treatment report provides market shares at global...

Market Overview The global renal cancer drug market size was valued at USD 6.36 Billion in 2024 and is anticipated to grow from USD 6.71 Billion in 2025 to reach USD 10.38 Billion by 2033, exhibiting a CAGR of 5.6% during the forecast period (2025–2033).  The global Renal Cancer Drug market continues to evolve rapidly, driven by shifting consumer...

Small Molecule Drug Discovery Market: Growth, Trends, Demand & Future Outlook to 2034 Market Snapshot The Small Molecule Drug Discovery Market is witnessing strong expansion as pharmaceutical and biotechnology companies increasingly invest in innovative therapies for chronic, infectious, and complex diseases. The market was valued at approximately USD 62.0 billion in...

Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...